OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
44
Results
Show all
Save search
Copy query
Show results for
Unknown
(44)
Publication Date
Release Date
2022
(6)
2020
(5)
2025
(4)
2013
(4)
2012
(4)
2023
(3)
2011
(3)
2024
(2)
2021
(2)
2019
(2)
2018
(2)
2014
(2)
2010
(2)
2017
(1)
2015
(1)
2009
(1)
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients.
Not available
S-EPMC4892373
|
biostudies-literature
Cite
Multi-omics approach dissects cis-regulatory mechanisms underlying North Carolina macular dystrophy, a retinal enhanceropathy.
Not available
S-EPMC9674966
|
biostudies-literature
Cite
Eradicating HIV-1 infection: seeking to clear a persistent pathogen.
Not available
S-EPMC4383747
|
biostudies-literature
Cite
Peripheral Vγ9Vδ2 T Cells Are a Novel Reservoir of Latent HIV Infection.
Not available
S-EPMC4608739
|
biostudies-literature
Cite
Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal Ex Vivo.
Not available
S-EPMC5974478
|
biostudies-literature
Cite
Variants in the ITPA gene protect against ribavirin-induced hemolytic anemia in HIV/HCV-coinfected patients with all HCV genotypes.
Not available
S-EPMC3283113
|
biostudies-literature
Cite
Brief Report: Toll-like Receptor 9-1635A/G Polymorphism Is Associated With HIV-1 Rebound After Four Weeks of Interruption of Antiretroviral Therapy.
Not available
S-EPMC10019827
|
biostudies-literature
Cite
Aminobisphosphonates reactivate the latent reservoir in people living with HIV-1.
Not available
S-EPMC10516574
|
biostudies-literature
Cite
MicroRNA-3148 modulates allelic expression of toll-like receptor 7 variant associated with systemic lupus erythematosus.
Not available
S-EPMC3585142
|
biostudies-literature
Cite
Safety and efficacy of dolutegravir in treatment-experienced subjects with raltegravir-resistant HIV type 1 infection: 24-week results of the VIKING Study.
Not available
S-EPMC3563307
|
biostudies-literature
Cite
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets